Abstract
Summary: PROTEGO is a Chilean cluster‐randomised crossover trial of vernix caseosa retention to prevent atopic dermatitis. 1383 mother‐infant dyads will be enrolled and followed for atopic dermatitis until 12 months.
Funding Information
  • Agencia Nacional de Investigación y Desarrollo (1241933)

This publication has 7 references indexed in Scilit: